Injex Pharma Inc (fka )

[blackleguan]

INJEX Pharma AG and American Healthcare Products Inc. signed an exclusive distributor agreement to market needle-free syringe INJEX 30 in the West Coast States of USA

14:20 17.08.12
DGAP-News: INJEX Pharma AG / Key word(s): Contract
INJEX Pharma AG and American Healthcare Products Inc. signed an
exclusive distributor agreement to market needle-free syringe INJEX 30
in the West Coast States of USA

17.08.2012 / 14:15


---------------------------------------------------------------------


INJEX Pharma AG and American Healthcare Products Inc. signed an exclusive
distributor agreement to market needle-free syringe INJEX 30 in the West
Coast States of USA

INJEX Pharma AG ISIN: DE000A0STYL7

Berlin, 17 August 2012

Berlin - American Healthcare Products Inc., headquartered in California,
has been appointed as the exclusive distributor for USA West Coast states
to market INJEX 30 in Washington State, California, Arizona, Nevada and
Oregon. The agreement, includes a fixed minimum volume of 20,000 INJEX
systems in the first year, was signed and the first delivery of products
will start soon in August.

'We are excited about the partnership with INJEX Pharma AG. With FDA 510K
approval for INJEX 30, we are very much convinced about the market
opportunities in the dental, diabetes and medical markets. INJEX is the
painless injection system and a safe alternative to the traditional needle
syringe and a solution for needle phobics. But above all INJEX is an
expression of the American way of life - basic rights of free choice for
patients - and INJEX - the needle-free injection system is the better
choice,' stated American Healthcare Products Inc. Managing Director Richard
Lim.

In October, American Healthcare Products Inc. will present and highlight
the INJEX 30 system and the needle-free treatments at the Annual Show of
the American Dental Association (ADA) to the American dentists.

'We are focused on our network opportunities and immediate market approach.
It's Time to market - we have the sales and marketing strategy in the
exclusive states prepared, the logistics built up and our long term
partners and customers integrated,' added Mr. Richard Lim.

'Together with American Healthcare Products Inc., we have a strong sales
and marketing partner, which has been established in the market,
experienced and has a first class network of institutions, associations and
clinics. This is fundamental for the sales opportunities and we are looking
forward to a successful market entry with our new partner in the US
market,' remarks Mr. Andy Rösch, CEO of INJEX Pharma AG.
Contact:

Andy Rösch
CEO
INJEX Pharma AG
Buckower Damm 114
12349 Berlin
Tel.: [phone]
[e-mail]
www.injex.com

Sylwin Grinman
Managing Director
INJEX Pharma USA
1922 NE 119 RD
North Miami Beach - FL - 33181
USA
Tel.: [phone]
[e-mail]
End of Corporate News


---------------------------------------------------------------------


17.08.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


http://www.dgap.de/news/corporate/injex-pharma-and-american-healthcare-products-inc-signed-exclusive-distributor-agreement-market-needlefree-syringe-injex-the-west-coast-states-usa_42269_729684.htm